Modified Donanemab Dosing Reduces ARIA-E in Adults with Early Symptomatic Alzheimer Disease
New phase 3b data suggest that a modified titration of donanemab reduces the risk of brain swelling and fluid accumulation at 24 weeks.
Pneumococcal 21-Valent Conjugate Vaccine in At-Risk Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
A Skin Cancer Triage Tool for Primary Care: One Specialist's Take on the DermaSensor Device
Dermatologist Rebecca Hartman, MD, MPH, said that reliable point-of-care screening results can help reduce unnecessary specialist referral for benign lesions.
Dermatologist Mona Shahriari, MD, Relies on Primary Care Colleagues as First-Line Prescribers for AD
Not all atopic dermatitis requires treatment by a specialist, says this dermatologist, and she collaborates regularly with her primary care colleagues.
Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy
Preliminary phase 1 data showed that RSV neutralizing antibodies for non-adjuvanted SCB-1019 matched GSK’s AS01E-adjuvanted RSV vaccine, Arexvy.
Lead Author Rebecca Hartman, MD, MPH, Highlights Unique Design of New DermaSensor Study
The DermaSensor skin cancer screening device was pitted against clinical impressions of lesions suspected with high confidence to be melanoma. Results, here.
Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose
The DermaSensor Device vs the Dermatologist and the Pathologist: Lead Author Details New Study
Dermatologists at high volume dermatology centers referred suspicious lesions to pathology for biopsy and diagnosis. The results were compared with DermaSensor read-outs.
Knowledge Gaps in How to Manage Anaphylaxis, Epinephrine Use, Persist for Patients, Even EMS
ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.
GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose
Survey Reveals Patient Concerns Over Colonoscopy Prep, Barriers to Procedure
More than half of US adults who had a colonoscopy in past 5 years said they wish they knew more information before their first procedure.
Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis
Rifaximin monotherapy may also confer a survival benefit, according to the study, which was awarded ACG Outstanding Research Award in the Liver Category.
A Melanoma Diagnosis is a 3-Part Process, Dermatologist Rebecca Hartman, MD, MPH, Explains
A rapid increase in the rate of melanoma diagnoses could be the result of multiple factors, explains the Harvard assistant professor of dermatology.
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.
Orexo Launches New OX640 Clinical Trial in People with Allergic Rhinitis
The company is advancing development of the intranasal epinephrine medication following positive phase 1 data.
New Data on Needle Free Epinephrine Spray Presented at ACAAI 2024
A summary of new data presented at the 2024 American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New Data
After 60 months of treatment, 38% of study participants with severe AD achieved complete remission.
Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study
Semaglutide significantly reduced risk of a first-time diagnosis of AD in a cohort of more than 1 million, suggesting an opportunity for controlled clinical trials.
New Drug Boosts COPD Lung Function, QoL Regardless of Severity: Daily Dose
Primary Care Assessment of Suspicious Skin Lesions: A Dermatologist Highlights DermaSensor
A bothersome skin lesion is typically first seen and assessed in primary care. An AI-based point-of-care device may help enhance triage, says Rebecca Hartman, MD, MPH.
